MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 3: Optimization of potency in the pyridopyrimidine series through the application of a pharmacophore model

Kiyoshi Nakayama, William J. Watkins, Kenichi Yoshida(Meiji University), Aesop Cho(Essential Research (United States)), Monica H. Palme(Essential Research (United States)), Haruko C. Kawato(Daiichi University of Pharmacy), Yoshihiro Yokomizo, Ving J. Lee(Essential Research (United States)), Jun Watanabe(Daiichi University of Pharmacy), Noriko Kuru, Masami Ohtsuka, Hiroko Ishida(Daiichi-Sankyo (Japan)), Toshiharu Ohta(Daiichi University of Pharmacy), Atsunobu Sakamoto, Jason Z. Zhang(Essential Research (United States)), Kazuki Hoshino, Kumi Yoshida(Aichi Institute of Technology)
Bioorganic & Medicinal Chemistry Letters
December 4, 2003
Cited by 65


Related Papers